Skip to main content

Advertisement

Table 1 Age, anthropometric data and clinical characteristics of the women studied

From: Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis

  PsA N =45 Ps N =52 Control N =98 P
Age (years) 60.5 ± 8.7 61.4 ± 9.1 60.1 ± 8.4 0.95
Weight (kg) 69.4 ± 8.9 71.1 ± 14.2 67.8 ± 11.2 0.19
Height (m) 1.50 ± 0.7 1.50 ± 0.6 1.55 ± 0.6 0.97
BMI (kg/m2) 29.1 ± 3.6 26.6 ± 6.2 28.1 ± 4.54 0.19
Within ideal weight range *     
N (%) 7 (15.6) 9 (17.3) 25 (25.5) 0.29
Overweight     
N (%) 17 (37.8) 22 (42.3) 40 (40.8) 0.9
Obese     
N (%) 21 (46.7) 21 (40.4) 33 (33.7) 0.31
Ps Duration (years) 24.8 ± 16.2 21.8 ± 17.8 - 0.39
PsA Duration (years) 11 ± 10.5 - - -
PASI 2.2 ± 3.3 3.2 ± 3.4 - 0.22
HAQ 0.7 ± 0.5§|| 0.2 ± 0.3 0.1 ± 0.2 <0.001
DAS28 3.7 ± 1.4 - - -
PsARC     
N° of swollen joints 3.2 ± 2.9 - - -
N° of painful joints 3.5 ± 3.4 - - -
Global evaluation of patient (VAS) 4 ± 2.8 - - -
Global evaluation of physician (VAS) 3.3 ± 2.4 - - -
Years since of menopause 12.7 ± 9.9 15.4 ± 10.9 12.1 ± 8.6 0.22
  1. *BMI 18.50 - 24.99 kg/m2; BMI 25 - 29.99 kg/m2; BMI ≥ 30 kg/m2
  2. DAS28, disease activity score 28; HAQ, health assessment questionnaire; PASI, psoriasis area severity index; PsA, psoriatic arthritis; Ps, psoriasis; PsARC, psoriatic arthritis response criteria; VAS, visual analogue scale.
  3. §P < 0.001 (PsA vs. Ps)
  4. ||P < 0.001 (PsA vs. control)